20.12.2023 - CARMEL, Ind., Dec. 20, 2023 (GLOBE NEWSWIRE) - NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children . Seite 1